Ulixertinib hydrochloride,
UNII-3K792HRQ8B,
3K792HRQ8B,
1956366-10-1,
4-(5-chloro-2-(isopropylamino)pyridin-4-yl)-N-((S)-1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide,
Ulixertinib (hydrochloride),
Vrt752271(HCl),
KS-00000LUS,
HY-15816A,
MFCD22543853,
BC623030,
DS-18785,
Ulixertinib (BVD-523 VRT752271),
Z-3205,
(S)-4-(5-Chloro-2-(isopropylamino)pyridin-4-yl)-N-(1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide hydrochloride,
1H-Pyrrole-2-carboxamide, 4-(5-chloro-2-((1-methylethyl)amino)-4-pyridinyl)-N-((1S)-1-(3-chlorophenyl)-2-hydroxyethyl)-, hydrochloride (1:1),
Ulixertinib,
Ulixertinib [INN],
UNII-16ZDH50O1U,
VRT752271,
869886-67-9,
1H-Pyrrole-2-carboxamide, 4-(5-chloro-2-((1-methylethyl)amino)-4-pyridinyl)-N-((1S)-1-(3-chlorophenyl)-2-hydroxyethyl)-,